NutriBand (NTRB) Equity Average (2016 - 2026)
NutriBand's (NTRB) quarterly Equity Average came in at $7.5 million in Q1 2026, down 14.52% year-on-year from $8.8 million in Q1 2025, and down 5.9% quarter-over-quarter from $8.0 million in Q4 2025.
NutriBand (NTRB) Equity Average (2016 - 2026) Analysis & Trends
NutriBand has disclosed Equity Average across 11 years of filings, most recently posting $7.5 million for Q1 2026.
- Equity Average for Q1 2026 came in at $7.5 million, down 14.52% year-over-year; the trailing twelve-month figure through Jan 2026 was $7.5 million (down 14.52% YoY), and the FY2026 annual result was $7.0 million, up 8.62% from the prior year.
- Equity Average came in at $7.5 million for Q1 2026 at NutriBand, down from $8.0 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $13.1 million in Q1 2022 to a low of $5.8 million in Q2 2025.
- The 5-year median for Equity Average is $8.8 million (2025), against an average of $9.1 million.
- Across the five-year window, Equity Average surged 88.01% in 2024 and tumbled 47.35% in 2025, its largest moves.
- NutriBand's Equity Average stood at $10.1 million in 2022, then slumped by 37.41% to $6.3 million in 2023, then soared by 88.01% to $11.8 million in 2024, then sank by 32.29% to $8.0 million in 2025, then declined by 5.9% to $7.5 million in 2026.
- The last three Equity Average figures came in at $7.5 million (Q1 2026), $8.0 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 516.41 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 7.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 7.55 Mn |
| Oct 31, 2025 | 8.02 Mn |
| Jul 31, 2025 | 6.80 Mn |
| Apr 30, 2025 | 5.77 Mn |
| Jan 31, 2025 | 8.83 Mn |
| Oct 31, 2024 | 11.85 Mn |
| Jul 31, 2024 | 12.91 Mn |
| Apr 30, 2024 | 9.90 Mn |
| Jan 31, 2024 | 6.07 Mn |
| Oct 31, 2023 | 6.30 Mn |
| Jul 31, 2023 | 7.31 Mn |
| Apr 30, 2023 | 8.15 Mn |
| Jan 31, 2023 | 9.15 Mn |
| Oct 31, 2022 | 10.07 Mn |
| Jul 31, 2022 | 10.74 Mn |
| Apr 30, 2022 | 11.47 Mn |
| Jan 31, 2022 | 13.09 Mn |
| Oct 31, 2021 | 10.82 Mn |
| Jul 31, 2021 | 7.58 Mn |
| Apr 30, 2021 | 7.47 Mn |